Tuesday, June 14, 2016 5:03:03 PM
I've looked through past EAPH PRs to find out when they estimated we'd have Mexican approval for the cancer drugs and the women's health products.In a PR date 9/15/15 they stated: Ackerman Pharma believes the approval [for the cancer drugs] "can be obtained by the end of 2015 or shortly into the New Year...
In a letter to shareholders dated 10/7/15 EAPH stated the women's health products will "undergo a fast-track process... in order to shorten the normally long two-three year approvals process down to months."
Well, here we are 8-9 months later and we're still waiting on Mexican approval for these products. Without that approval this company becomes very questionable; with it there may be some potential for a share price increase.
Why is the company not updating us on this situation? Comments welcome.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM